ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,969.86
1.75%
Dow Jones
43,120.41
1.84%
US Dollar vs MXN
20.08485
-1.30%
Brent Oil
72.76
0.52%
Bitcoin
97,175.21
-0.29%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Icade (ICAD) Cotización

Icade

Icade (ICAD)

Icad Inc
21.52
0.36
(1.70%)
Cerrado 20 Diciembre 10:30AM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
21.52
Postura de Compra
21.24
Postura de Venta
21.54
Volume Operado de la Acción
148,252
20.98 Rango del Día 21.58
19.36 Rango de 52 semanas 36.38
Capitalización de Mercado [m]
1.631B
Precio Anterior
21.16
Precio de Apertura
21.02
Hora
885
@
21.52
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
130,209
Acciones en circulación
75,777,866
Rendimiento del Dividendo
22.49%
Ratio Precio/Utilidad
-1.30
Beneficio por acción (BPA)
-16.5
turnover
2.02B
Beneficio neto
-1.25B

Acerca de Icade

Sector
Operators-nonres Bldgs
Industria
Public Warehousing & Storage
Sitio web
www.icade.fr
Sede
Issy-les-moulineaux, Hauts-de-seine, Fra
Fundado
1954
Icade is listed in the Operators-nonres Bldgs sector of the Euronext with ticker ICAD. The last closing price for Icade was 21.16 €. Over the last year, Icade shares have traded in a share price range of 19.36 € to 36.38 €.

Icade currently has 75,777,866 shares in issue. The market capitalisation of Icade is 1.60 € billion. Icade has a price to earnings ratio (PE ratio) of -1.30.

ICAD Últimas noticias

Más noticias

Cohen & Steers Announces Change in Global Realty Majors Portfolio Index

Cohen & Steers Announces Change in Global Realty Majors Portfolio Index PR Newswire NEW YORK, Nov. 14, 2014 NEW YORK, Nov. 14, 2014 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS...

14 Noviembre 2014
PR Newswire (US)

iCAD to Present at Canaccord Adams 27th Annual Global Growth Conference

NASHUA, N.H., July 25 /PRNewswire-FirstCall/ -- iCAD, Inc. (NASDAQ:iCAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today...

25 Julio 2007
PR Newswire (US)

iCAD CEO Ken Ferry to Speak at the 2007 Future in Review Conference

NASHUA, N.H., May 22 /PRNewswire-FirstCall/ -- iCAD, Inc. (NASDAQ:iCAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today...

22 Mayo 2007
PR Newswire (US)

iCAD Reports First Quarter 2006 Operating Results

NASHUA, N.H., April 27 /PRNewswire-FirstCall/ -- iCAD(R), Inc. (NASDAQ: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer...

27 Abril 2006
PR Newswire (US)

iCAD Reports 2005 Operating Results

Fourth Quarter Sales Increase 82% from Third Quarter Levels NASHUA, N.H., March 14 /PRNewswire-FirstCall/ -- iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of Computer-Aided Detection...

14 Marzo 2006
PR Newswire (US)

iCAD to Present at AeA Classic

NASHUA, N.H., Nov. 1 /PRNewswire-FirstCall/ -- iCAD(R), Inc. (NASDAQ: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions, today announced that W. Scott Parr...

01 Noviembre 2005
PR Newswire (US)

iCAD Signs Contract with Amerinet for SecondLook(R) Computer Aided Detection Systems

Amerinet Members Now Have Access to Savings on Early Breast Cancer Detection NASHUA, N.H., Oct. 27 /PRNewswire-FirstCall/ -- iCAD(R), Inc. (NASDAQ: ICAD), an industry-leading provider of...

27 Octubre 2005
PR Newswire (US)

iCAD Introduces PowerLook(TM) for its SecondLook(R) CAD Viewers

-- New CAD Viewer Provides Digital Viewing Support to Film Based Mammography -- NASHUA, N.H., Oct. 24 /PRNewswire-FirstCall/ -- iCAD(R), Inc. (NASDAQ: ICAD), an industry-leading provider of...

24 Octubre 2005
PR Newswire (US)

iCAD Schedules Third Quarter Conference Call for Thursday, October 27, 2005

NASHUA, N.H., Oct. 21 /PRNewswire-FirstCall/ -- iCAD(R), Inc. (NASDAQ: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer...

21 Octubre 2005
PR Newswire (US)

iCAD Introduces New TotalLook Product for Growing Digital Mammography Market

- Assists in Conversion to Digital Mammography by Enhancing Comparative Review of Previous Film and Current Digital Mammograms - NASHUA, N.H., Oct. 7 /PRNewswire-FirstCall/ -- iCAD(R), Inc...

07 Octubre 2005
PR Newswire (US)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.72-3.2374100719422.2422.4220.9813065021.55535526DE
4-0.78-3.4977578475322.323.6820.9813742822.20234195DE
12-5.86-21.402483564627.3827.7420.9813020923.65759674DE
26-3.8-15.007898894225.3227.9819.3613030523.20385306DE
52-13.88-39.20903954835.436.3819.3612329925.45189459DE
156-39.28-64.605263157960.866.619.369803636.26984998DE
260-72.43-77.09419904293.9510619.369667947.44872589DE

ICAD - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Icade?
El precio actual de las acciones de Icade es 21.52 €
¿Cuántas acciones de Icade están en circulación?
Icade tiene 75,777,866 acciones en circulación
¿Cuál es la capitalización de mercado de Icade?
La capitalización de mercado de Icade es EUR 1.6B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Icade?
Icade ha negociado en un rango de 19.36 € a 36.38 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Icade?
El ratio precio/beneficio de Icade es -1.3
¿Cuál es el ratio de efectivo a ventas de Icade?
El ratio de efectivo a ventas de Icade es 0.81
¿Cuál es la moneda de reporte de Icade?
Icade presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Icade?
El último ingresos anual de Icade es EUR 2.02B
¿Cuál es el último beneficio anual de Icade?
El último beneficio anual de Icade es EUR -1.25B
¿Cuál es la dirección registrada de Icade?
La dirección registrada de Icade es IMMEUBLE OPEN 27 RUE CAMILLE DESMOULINS, ISSY-LES-MOULINEAUX, HAUTS-DE-SEINE, 92445
¿Cuál es la dirección del sitio web de Icade?
La dirección del sitio web de Icade es www.icade.fr
¿En qué sector industrial opera Icade?
Icade opera en el sector PUBLIC WAREHOUSING & STORAGE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TMBSZTME Pharma NV
0.02 €
(185.71%)
132.5k
MLGEQGentlemen S Equity SA
0.0175 €
(118.75%)
1.14k
ALCYBCybergun
0.0002 €
(100.00%)
17.54M
MLAAHAmatheon Agri Holding NV
0.0185 €
(54.17%)
40.1k
ALARFAdeunis
0.94 €
(28.77%)
5.27k
MLSMLSmalto
0.0125 €
(-37.50%)
2.34k
MLFTIFrance Tourisme Immobilier
0.025 €
(-35.90%)
56.77k
CNVCnova NV
0.209 €
(-19.62%)
26.38k
MLWEAWeaccess Group
0.382 €
(-16.96%)
5.95k
ALEUPEuroplasma
0.0353 €
(-15.95%)
3.16M
ATOAtos SE
0.0021 €
(0.00%)
2.71B
BCPBanco Comercial Portugues SA
0.4493 €
(-0.69%)
66.54M
ALHGLouis Hachette Group
1.3342 €
(4.87%)
52.04M
KPNKoninklijke KPN NV
3.509 €
(-1.21%)
26.9M
VIVVivendi SE
2.51 €
(2.41%)
26.39M

Discusión

Ver feed completo
wshaw14 wshaw14 1 minuto hace
https://www.msn.com/en-us/money/other/energy-transfer-subsidiary-signs-20-year-lng-supply-deal-with-chevron/ar-AA1weN9H?ocid=BingNewsVerp
ET
rodman rodman 1 minuto hace
Hopefully RFK and DOGE can rid the FDA of its in-efficiency and corruption that has been pervasive in the pharmaceutical industry for years! In the meantime here we are!
https://www.greenlight.guru/blog/fda-medical-device-approval-process
$5-$10+
UEEC
RobotDroid RobotDroid 1 minuto hace
The thing everyone is missing is how many mistakes are in the bloated 1.7 million pages. Obviously many. LPoop screwed the submission up, thus the silence
NWBO
NoMoDo NoMoDo 1 minuto hace
That is him. Now... for the bonus round... where have we seen him before?
HMBL
Techroemancer Techroemancer 1 minuto hace
You mean when he got hired on to test if the product is able to be safely applied to skin? Lmao. Too easy to refute your wild conspiracies.
MGON
lizzy241 lizzy241 1 minuto hace
Sleven, the formulary for CVS Caremark shows Vascepa at tier 2. In 2024, it was tier 3. I found the below on page 30 of their formulary. Why the discrepancy?

SOAJ 140mg/ml
2 NM PA
VASCEPA CAPS .5gm, 1gm 2
VYTORIN TAB 10-10MG
QL (30 tabs / 30 days)
CVS
Steady_T Steady_T 1 minuto hace
That is a reasonable approach. Less risk/less reward.

If history is a guide there will be a big move up on approval and then a beat down by the mysterious forces on the market.
There may not be a beat down if approval is followed up by additional news.

I certainl
AVXL
gdl gdl 1 minuto hace
Nasdaq, S&P, Dow soar 2% each as soft inflation data helps overcome Fed 'overreaction

Yup over reaction. Like Trumps Chaos. Like a Pandemic. Like current valuations.

Bubblegum delicious. Trump can’t wait till January 20th to start his dictionary reign. I love his
blackhawks blackhawks 2 minutos hace
Who's a good boy?

https://x.com/AmoneyResists/status/1870002702257926399
linkvest linkvest 2 minutos hace
I grabbed some 13s but these 14s looks so cute not to have a few.
RDAR
budfoxfun budfoxfun 2 minutos hace
$SGTM Aired on Fox Business https://finance.yahoo.com/news/street-show-617-airs-tonight-035500854.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
SGTM
ATVrider ATVrider 2 minutos hace
I’ve got 200 at $44 and 100 under $40. My first buy was at $8,5 but sold too soon at $30. I am sure we have bottomed out but we shall see ! I am ready for triple digits aswell !
NUKK
XMaster2023 XMaster2023 2 minutos hace
Yes many shorts and paid posters employed by the market makers and/or BP that have many eyes and no brain.
NWBO
Banjo50 Banjo50 2 minutos hace
I think it should be five cents. I bid five cents EACH FOR 1,000 SHARES!!!
ME
Lone Clone Lone Clone 2 minutos hace
Colibri and Partne Tocvanr to Begin Diamond Drilling at Pilar, Closes Financing

https://www.newsfilecorp.com/release/234656/Colibri-and-Partner-to-Begin-Diamond-Drilling-at-Pilar-and-Closes-Financing

December 20, 2024 8:25 AM EST | Source: Colibri Resource Corporation
linkvest linkvest 3 minutos hace
This would make your RDAR stand out in your stock portfolio Gregg... Big numbers are always easier to see. Only about 14 million left of the 14s. Easy peasy
RDAR
Jahvik Jahvik 3 minutos hace
Is this him?

https://orenlitwinlaw.com/
HMBL
martyDg martyDg 3 minutos hace
The data you gathered doesn't tell you you're right. lol. again, your arrogance about being correct because of your data will put you to the right place. Merck did not say who it's for and you don't work for them. You need to have some DOUBTS sometimes Overconfidence will do no good to you.
NWBO
RIGATONI RIGATONI 3 minutos hace
.0014 hits, the DTC numbers working out nicely again with what was added recently. Looking great, like to see north of 100M volume again ~Rig
DTC
TURCH TURCH 3 minutos hace
Headed back there IMO


Regards
ASKH
attilathehunt attilathehunt 3 minutos hace
If Merck is truly spending billions on the buildout then surely a deal is worked out predicated on approval.

If such is the xcase, then there will not be a bidding war, since Merck most likely wrapped up the science with NWBO and they are waiting for approval as we are.
NWBO
blackhawks blackhawks 4 minutos hace
Who's a good boy?

https://x.com/AmoneyResists/status/1870002702257926399
Timing101 Timing101 4 minutos hace
$APCX Back on the move today. HOWEVER, What folks need to know are about the Technology and Patents APPTECH ($APCX) have , with Proprietary Intellectual Property in the Market . They are being used by companies such as PAYTOME, the #2 rated start up (see link below , I always supply) in the AI
APCX

Su Consulta Reciente

EU
ICAD
Icade
BTRX
MQLUSDT
MiraQle
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados